Arrowhead Pharmaceuticals, Inc. today announced new results from the Phase 3 PALISADE study and the open-label extension from the Phase 2 MUIR and SHASTA-2 studies of investigational plozasiran. These ...
Treatment of hyperlipidemia Therapeutic lifestyle changes are an important component of hyperlipidemia treatment, since Type 2 diabetes mellitus, hypertension, obesity and physical inactivity are ...
Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...
On Tuesday, Nov. 5, as part of the Johns Hopkins Medicine’s Department of Neurology and Neurosurgery Neuroimmunology Seminar Series, Dr. Amber Salter delivered an overview of her ongoing work ...
Total Revenue Increased 52% Year-over-Year to $51.6 Million with U.S. Net Product Revenue of $31.1 Million, Representing 53% Growth –– Total ...
Prioritising eye health through timely check-ups and proactive management is crucial for individuals with diabetes to ...
The National Human Rights Commission of Korea urged a prison warden to minimize the use of restraint devices, saying that ...
Although statins remain the predominant pharmacological treatment for hyperlipidemia, their associated side effects have led to a growing interest in alternative therapeutic approaches. Traditional ...
The New Drug Application is based on positive results from the Phase 3 PALISADE study – People living with familial chylomicronemia syndrome have extremely high triglyceride ...
Nearly three decades later, drug makers have developed six approved small interfering RNA (siRNA) therapeutics in the ...
An Arkansas Legislative Council subcommittee has recommended that the state's health insurance plans for public school and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback